International Clinical Trial: A Single-Arm, Open-Label Clinical Study of Short-Range Radiotherapy Sequential Aipalolito Vorolizumab Combined with CAPOX Neoadjuvant Therapy for Locally Advanced Rectal Cancer with Deficient Mismatch Repair (pMMR)/Microsatellite Stable (MSS)

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122106) titled 'A Single-Arm, Open-Label Clinical Study of Short-Range Radiotherapy Sequential Aipalolito Vorolizumab Combined with CAPOX Neoadjuvant Therapy for Locally Advanced Rectal Cancer with Deficient Mismatch Repair (pMMR)/Microsatellite Stable (MSS)' on April 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

Condition: Colorectal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-09

Target Sample Size: Experimental group:30;

Countries of Recruitment: China

To know more, visit https://www....